SCHEMBL6429382

SCHEMBL6429382

COC(=O)c1cccn1NC(=O)Nc1ccc(C2=CC(N3CCOCC3)CCC2)c2ccccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.33
MAPK13 O15264 2/20 0.33
MAPK12 P53778 2/20 0.33
MAPK11 Q15759 2/20 0.33
GRM5 P41594 1/20 0.32
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ABL1 P00519 1/20 0.31
EGFR P00533 1/20 0.31
RAF1 P04049 1/20 0.31
LYN P07948 1/20 0.31
BRAF P15056 1/20 0.31
EPHA2 P29317 1/20 0.31
EPHA3 P29320 1/20 0.31
AKT1 P31749 1/20 0.31
MAPK9 P45984 1/20 0.31
SHMT2 P34897 1/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4092099 0.78 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11ABL1
SCHEMBL4092785 0.72 MAPK14 (0.41) MAPK14MAPK13MAPK12MAPK11ABL1
SCHEMBL4081991 0.72 ABL1 (0.61) MAPK14MAPK13MAPK12MAPK11ABL1
SCHEMBL4092473 0.70 ABL1 (0.60) MAPK14MAPK13MAPK12MAPK11ABL1
SCHEMBL28673163 0.54 CNR2 (0.47) ALDH1A1
SCHEMBL20689624 0.54 TYK2 (0.47) ALDH1A1KDM4ENPC1RAB9AALOX15
SCHEMBL1966568 0.53 NR1H2 (0.39) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL4464429 0.53 PIK3CA (0.52) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL14791071 0.52 MAPT (0.37) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL26246483 0.52 CNR2 (0.39) ALDH1A1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1496900-A2 NEW PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND P38 KINASE INHIBITORS Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2005-01-19 EP disclosed
WO-2003084539-A2 NEW PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND P38 KINASE INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-10-16 WO disclosed